Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

Market Analysis and Insights: Global Mycoplasma Diagnostics Market
The global Mycoplasma Diagnostics market size is projected to reach US$ 998.5 million by 2027, from US$ 660.6 million in 2020, at a CAGR of 6.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mycoplasma Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mycoplasma Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mycoplasma Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mycoplasma Diagnostics market.

Global Mycoplasma Diagnostics Scope and Market Size
Mycoplasma Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mycoplasma Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Kits & Reagents
Instruments
Software & Services

Segment by Application
Hospitals
Diagnostic Laboratories
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche